An Analysis of Treatment Timelines for Lung Cancer Patients Across System Evolutions
This study is a single center, minimal risk, physician initiated retrospective chart review. An analysis of treatment timelines for patients diagnosed with lung cancer within the St. Elizabeth system from January 2013 until study completion. The study investigator and designee(s) will review patient electronic medical records, extracting data related to the symptom presentation, diagnosis, and treatment of new diagnoses of lung cancer. Collected data will focus on dates of encounters, diagnostic imaging/procedures, and treatments, with data analysis evaluating time between care encounters and potential delays in care. The data will be further stratified based on system-wide changes implemented to improve efficiency, patient outcomes, and patient experience.
Checked against the public recordLast updated Jul 12, 2024 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Not specified
- Study type
- Observational
- Phase
- Not applicable
- Sponsor
- St Elizabeth Healthcare
- Interventions being studied
- Not specified
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * Patient seen within the St. Elizabeth system * \>=18 years of age * New diagnosis of histologically or cytologically documented primary lung cancer diagnosed January 2013 or later Exclusion Criteria: * Patients with metastatic lung disease of other primary * Other malignancies at investigator's discretion * Patient received treatment at a facility outside of St. Elizabeth where records are not available through EPIC * Patient currently undergoing treatment for new diagnosis of lung cancer
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- St. Elizabeth HealthcareEdgewood, Kentucky
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jul 12, 2024. Always confirm current availability with the study team.